Meyka Pro banner
Garden Stage Limited

Garden Stage Limited Fundamental Analysis (NASDAQ: GSIW)

GSIWNASDAQ
Financial ServicesFinancial - Capital Markets
$15.55
$1.95(14.34%)
U.S. Market opens in 13h 28m

Garden Stage Limited Fundamental Analysis (NASDAQ: GSIW)

Garden Stage Limited (NASDAQ: GSIW) shows weak financial fundamentals with a PE ratio of -21.40, profit margin of -1.90%, and ROE of -62.79%. The company generates $0.0B in annual revenue with weak year-over-year growth of 2.96%.

Key Strengths

Cash Position11.34%
PEG Ratio-0.00
Current Ratio326.02

Areas of Concern

ROE-62.79%
Operating Margin-1.90%
We analyze GSIW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -156.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-156.0/100

We analyze GSIW's fundamental strength across five key dimensions:

Efficiency Score

Weak

GSIW struggles to generate sufficient returns from assets.

ROA > 10%
-33.01%

Valuation Score

Excellent

GSIW trades at attractive valuation levels.

PE < 25
-21.40
PEG Ratio < 2
-0.00

Growth Score

Weak

GSIW faces weak or negative growth trends.

Revenue Growth > 5%
2.96%
EPS Growth > 10%
3.45%

Financial Health Score

Excellent

GSIW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
326.02

Profitability Score

Weak

GSIW struggles to sustain strong margins.

ROE > 15%
-6279.26%
Net Margin ≥ 15%
-1.90%
Positive Free Cash Flow
No

Key Financial Metrics

Is GSIW Expensive or Cheap?

P/E Ratio

GSIW trades at -21.40 times earnings. This suggests potential undervaluation.

-21.40

PEG Ratio

When adjusting for growth, GSIW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Garden Stage Limited at 6.82 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.82

EV/EBITDA

Enterprise value stands at -3.08 times EBITDA. This is generally considered low.

-3.08

How Well Does GSIW Make Money?

Net Profit Margin

For every $100 in sales, Garden Stage Limited keeps $-1.90 as profit after all expenses.

-1.90%

Operating Margin

Core operations generate -1.90 in profit for every $100 in revenue, before interest and taxes.

-1.90%

ROE

Management delivers $-62.79 in profit for every $100 of shareholder equity.

-62.79%

ROA

Garden Stage Limited generates $-33.01 in profit for every $100 in assets, demonstrating efficient asset deployment.

-33.01%

Following the Money - Real Cash Generation

Operating Cash Flow

Garden Stage Limited generates limited operating cash flow of $-558.30K, signaling weaker underlying cash strength.

$-558.30K

Free Cash Flow

Garden Stage Limited generates weak or negative free cash flow of $-572.10K, restricting financial flexibility.

$-572.10K

FCF Per Share

Each share generates $-0.41 in free cash annually.

$-0.41

FCF Yield

GSIW converts -19.76% of its market value into free cash.

-19.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-21.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.82

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.99

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.003

vs 25 benchmark

Current Ratio

Current assets to current liabilities

326.02

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.63

vs 25 benchmark

ROA

Return on assets percentage

-0.33

vs 25 benchmark

ROCE

Return on capital employed

-0.33

vs 25 benchmark

How GSIW Stacks Against Its Sector Peers

MetricGSIW ValueSector AveragePerformance
P/E Ratio-21.4021.17 Better (Cheaper)
ROE-62.79%668.00% Weak
Net Margin-190.12%876.00% Weak
Debt/Equity0.000.79 Strong (Low Leverage)
Current Ratio326.02905.28 Strong Liquidity
ROA-33.01%4787782.00% Weak

GSIW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Garden Stage Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-13.65%

Industry Style: Value, Dividend, Cyclical

Declining

EPS CAGR

-1157.78%

Industry Style: Value, Dividend, Cyclical

Declining

FCF CAGR

-110.51%

Industry Style: Value, Dividend, Cyclical

Declining

Fundamental Analysis FAQ